Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06399432 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Mediterranean Diet vs no Dietary Intervention for Improving Signs and Symptoms of Psoriasis in Patients Treated With Anti-IL-17 or Anti-IL-23 Inhibitors

StatusRecruiting
PhaseNot applicable
Started2022-10-18
View on ClinicalTrials.gov ↗
In this study, participants will have 3 or 4 total study visits over approximately 10 total weeks. There is a two week medication washout period in between the 1st and 2nd visits. This washout only applies if participants are using a prohibited psoriasis medication (such as topical steroids or oral psoriasis medications, like methotrexate). During the washout period, participants will have to stop the prohibited medication(s). If participants are not using any prohibited medications, then the 1st and 2nd visits can be combined and participants will only have 3 total in-person visits. Participants will be randomly assigned (by chance; like flipping a coin) to either the Mediterranean Diet or no dietary intervention. After 4 weeks on the diet, participants will start treatment with either Anti-IL-17 or Anti-IL-23 therapy. The biologic treatments will prescribed by the participants regular dermatologist and not as a part of the study.

Amendment history 2 changes detected by DataLookout

2026-09-05
critical
Primary completion pushed: 2026-07-01 → 2027-01-01
2026-09-05
minor
Completion pushed: 2026-07-01 → 2027-01-01
Trial Details
NCT Number NCT06399432
Lead Sponsor University Hospitals Cleveland Medical Center
Conditions Psoriasis
Enrollment 36 participants
Start Date 2022-10-18
Primary Completion 2027-01-01 (estimated)
Study Completion 2027-01-01 (estimated)
Updated on ClinicalTrials.gov 2026-09-04